MedTrace Logo

Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer

NCT00471029 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-05-09

No results posted yet for this study

Summary

The purpose of this study is to compare the gastric acid suppression profile among different regimen (Oral Vs Intravenous)of administration of proton pump inhibitor - Esomeprazole by 24hours intragastric pH monitoring.

Conditions

  • Peptic Ulcer

Interventions

DRUG

esomeprazole

Sponsors & Collaborators

  • Pamela Youde Nethersole Eastern Hospital

    lead OTHER

Principal Investigators

  • Simon K.H. Wong, MBChB, FRCSEd, FHKAM · Pamela Youde Nethersole Hospital - Surgery

  • Michael K.W. Li, MD · PYNEH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2007-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471029 on ClinicalTrials.gov